How resilient manufacturing and supply chains keep medical supplies flowing

Published: 20-Jan-2026
Distribution

The reliability of the medical supply chain is fundamentally linked to global public health security, writes Lesley Barton (pictured), National Clinical and Training Manager, Bunzl and AMHC

You need to be a subscriber to read this article.
Click here to find out more.

Recent crises have underscored a critical fragility within pharmaceutical and medical device networks, which means that for healthcare manufacturing and operations leaders, resilience is now an operational imperative, not just a strategic goal

A truly resilient operational structure, encompassing robust manufacturing sites and adaptive supply chains, acts as the strongest defence against systemic shocks.

This prevents medical supply shortages and safeguards uninterrupted patient care by derisking the complex journey of active pharmaceutical ingredients (APIs), excipients and finished products. This ensures that essential supplies arrive reliably, regardless of external volatility. 

Not yet a Subscriber?

This is a small extract of the full article which is available ONLY to premium content subscribers. Click below to get premium content on Manufacturing Chemist.

Subscribe now Already a subscriber? Sign in here.
See more

You may also like

Distribution

EyeC appoints Beijing Transwest Automation as Chinese distribution partner

Read more
The new partnership will give printers and packaging manufacturers in China direct access to EyeC’s innovative quality control solutions, as well as on-site service and technical support

Trending Articles

  1. EyeC appoints Beijing Transwest Automation as Chinese distribution partner The new partnership will give printers and packaging manufacturers in China direct access to EyeC’s innovative quality control solutions, as well as on-site service and technical support
  2. Fastest growing firms named in new Plimsoll analysis Report provides an in-depth industry analysis of the leading players in the market
  3. Futura's ED treatment gel receives approval in Saudi Arabia Futura Medical's distribution partner Labatec Pharma has received received regulatory approval for MED3000, the gel-based ED treatment, in Saudi Arabia
  4. Biesterfeld and Jubilant celebrate 25 year partnership on fine chemicals Biesterfeld Spezialchemie distributes Jubilant Ingrevia’s selected range of products in the field of advanced intermediates to selected customers across Europe
  5. Mastering cold-storage management: strategies to minimise pharmaceutical losses Insufficient temperature control during pharmaceutical distribution accounts for $35 billion in losses each year, highlighting the importance of developing mitigation strategies to overcome this issue

Upcoming event

Pharmapack

21–22 January 2026 | Exhibition | Paris, France See all

You may also like

Distribution

EyeC appoints Beijing Transwest Automation as Chinese distribution partner

The new partnership will give printers and packaging manufacturers in China direct access to EyeC’s innovative quality control solutions, as well as on-site service and technical support
Distribution

Yusen Logistics Group completes acquisition of Walden Health, strengthening global healthcare logistics capabilities

Yusen Logistics Global Management is pleased to announce that Yusen Logistics (Europe) BV, an overseas subsidiary of Yusen Logistics Group, has completed the acquisition of the Walden Group subsidiaries Movianto, Eurotranspharma, Transpharma International and Walden Digital
You need to be a subscriber to read this article.
Click here to find out more.
Distribution

Using seamless, scalable technology to reshape the pharma supply chain and meet patients where they are

This article explores how innovative technology can transform the pharmaceutical supply chain by ensuring timely access to vital medications for patients worldwide
Distribution

KLIFO secures regulatory approval for advanced clinical trial supply facility in Copenhagen

KLIFO’s new facility receives Manufacturing and Importation Authorisation from the Danish Medicines Agency, expanding capacity for global clinical trials with enhanced temperature control, light-sensitive handling and flexible supply chain solutions
Distribution

Cold Chain Technologies launches “Smart Chain, Clear Gain” campaign to elevate digitalisation in pharma logistics

Leading temperature-controlled solution provider, Cold Chain Technologies (CCT), has unveiled its new campaign, Smart Chain, Clear Gain, aimed to redefine how pharmaceutical companies approach compliance, efficiency and value in cold chain logistics
Distribution

Er-Kim partners with Sentynl Therapeutics to expand access to ultra-rare disease treatments Nulibry and Zokinvy

The collaboration aims to provide timely access to these EMA- and FDA-approved therapies for patients with life-threatening ultra-rare conditions, including molybdenum cofactor deficiency Type A and Hutchinson-Gilford Progeria Syndrome
Distribution

Atelerix and CliniSciences enter agreement to expand access to cryo-free cell preservation

The partnership expands Atelerix’s operational footprint across Europe and into North Africa, enhancing local technical support and meeting rising demand for innovative, energy-efficient alternatives to cryopreservation
Subscribe now